The Ethics and Governance of Human Genetic Databases 2007
DOI: 10.1017/cbo9780511611087.007
|View full text |Cite
|
Sign up to set email alerts
|

Iceland

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2008
2008
2012
2012

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 0 publications
0
3
0
Order By: Relevance
“…9 Factual recruitment rates in the Icelandic Cancer Project (ICP) during 2001-2002 were higher: 88% of eligible patients and 82% of controls agreed to open-ended storage of samples for use in other cancer research projects, including genetic and commercial research. 25 In 2002, the willingness to join the UK Biobank was estimated to 34%.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…9 Factual recruitment rates in the Icelandic Cancer Project (ICP) during 2001-2002 were higher: 88% of eligible patients and 82% of controls agreed to open-ended storage of samples for use in other cancer research projects, including genetic and commercial research. 25 In 2002, the willingness to join the UK Biobank was estimated to 34%.…”
Section: Resultsmentioning
confidence: 99%
“…By tracking references from contemporary literature on public attitudes to biobank research, we identified nine public attitude surveys from Sweden, 2,8 Iceland, 9 the United Kingdom, 10 Ireland, 11 the United States, [12][13][14] and Singapore 15 addressing willingness to participate in biobank research or to store samples for future research. As sample donors are often recruited in health care, we also included two British surveys conducted on patients.…”
Section: Methodsmentioning
confidence: 99%
“…This is generally interpreted as support of a consent requirement (Merz, 1997), but whether people prefer broad (Chen et al, 2005) or specific consent (Eriksson, 2007;Human Genetics Commission, 2000), and when and under which conditions differs remarkably between the surveys. 4) Commercial access to public biobanks is accepted by a majority Stegmayr and Asplund, 2002); nevertheless, it is viewed more as a necessary evil than as the preferred research infrastructure (e.g., Cragg Ross Dawson, 2000;Gudmundsdóttir and Nordal, 2007). In a British survey, for example, genetic research results were viewed as belonging to the public (Human Genetics Commission, 2000).…”
Section: Donor Perspectivesmentioning
confidence: 99%